74 related articles for article (PubMed ID: 35267415)
61. Xerostomia: a day and night difference.
Dijkema T; Raaijmakers CP; Braam PM; Roesink JM; Monninkhof EM; Terhaard CH
Radiother Oncol; 2012 Aug; 104(2):219-23. PubMed ID: 22809589
[TBL] [Abstract][Full Text] [Related]
62. Dose-response analysis of acute oral mucositis and pharyngeal dysphagia in patients receiving induction chemotherapy followed by concomitant chemo-IMRT for head and neck cancer.
Bhide SA; Gulliford S; Schick U; Miah A; Zaidi S; Newbold K; Nutting CM; Harrington KJ
Radiother Oncol; 2012 Apr; 103(1):88-91. PubMed ID: 22280809
[TBL] [Abstract][Full Text] [Related]
63. Predictive modelling for swallowing dysfunction after primary (chemo)radiation: results of a prospective observational study.
Christianen ME; Schilstra C; Beetz I; Muijs CT; Chouvalova O; Burlage FR; Doornaert P; Koken PW; Leemans CR; Rinkel RN; de Bruijn MJ; de Bock GH; Roodenburg JL; van der Laan BF; Slotman BJ; Verdonck-de Leeuw IM; Bijl HP; Langendijk JA
Radiother Oncol; 2012 Oct; 105(1):107-14. PubMed ID: 21907437
[TBL] [Abstract][Full Text] [Related]
64. Chemo-IMRT of oropharyngeal cancer aiming to reduce dysphagia: swallowing organs late complication probabilities and dosimetric correlates.
Eisbruch A; Kim HM; Feng FY; Lyden TH; Haxer MJ; Feng M; Worden FP; Bradford CR; Prince ME; Moyer JS; Wolf GT; Chepeha DB; Ten Haken RK
Int J Radiat Oncol Biol Phys; 2011 Nov; 81(3):e93-9. PubMed ID: 21592678
[TBL] [Abstract][Full Text] [Related]
65. Risk factors for radiation-induced hypothyroidism: a literature-based meta-analysis.
Vogelius IR; Bentzen SM; Maraldo MV; Petersen PM; Specht L
Cancer; 2011 Dec; 117(23):5250-60. PubMed ID: 21567385
[TBL] [Abstract][Full Text] [Related]
66. Use of normal tissue complication probability models in the clinic.
Marks LB; Yorke ED; Jackson A; Ten Haken RK; Constine LS; Eisbruch A; Bentzen SM; Nam J; Deasy JO
Int J Radiat Oncol Biol Phys; 2010 Mar; 76(3 Suppl):S10-9. PubMed ID: 20171502
[TBL] [Abstract][Full Text] [Related]
67. NTCP modeling of subacute/late laryngeal edema scored by fiberoptic examination.
Rancati T; Fiorino C; Sanguineti G
Int J Radiat Oncol Biol Phys; 2009 Nov; 75(3):915-23. PubMed ID: 19747783
[TBL] [Abstract][Full Text] [Related]
68. Intensity-modulated proton therapy versus helical tomotherapy in nasopharynx cancer: planning comparison and NTCP evaluation.
Widesott L; Pierelli A; Fiorino C; Dell'oca I; Broggi S; Cattaneo GM; Di Muzio N; Fazio F; Calandrino R; Schwarz M
Int J Radiat Oncol Biol Phys; 2008 Oct; 72(2):589-96. PubMed ID: 18793962
[TBL] [Abstract][Full Text] [Related]
69. Intensity-modulated radiotherapy of nasopharyngeal carcinoma: a comparative treatment planning study of photons and protons.
Taheri-Kadkhoda Z; Björk-Eriksson T; Nill S; Wilkens JJ; Oelfke U; Johansson KA; Huber PE; Münter MW
Radiat Oncol; 2008 Jan; 3():4. PubMed ID: 18218078
[TBL] [Abstract][Full Text] [Related]
70. Quantitative dose-volume response analysis of changes in parotid gland function after radiotherapy in the head-and-neck region.
Roesink JM; Moerland MA; Battermann JJ; Hordijk GJ; Terhaard CH
Int J Radiat Oncol Biol Phys; 2001 Nov; 51(4):938-46. PubMed ID: 11704314
[TBL] [Abstract][Full Text] [Related]
71. Proton therapy for carcinoma of the nasopharynx: a study in comparative treatment planning.
Brown AP; Urie MM; Chisin R; Suit HD
Int J Radiat Oncol Biol Phys; 1989 Jun; 16(6):1607-14. PubMed ID: 2542199
[TBL] [Abstract][Full Text] [Related]
72. Proton Radiation Therapy for Nasopharyngeal Cancer Patients: Dosimetric and NTCP Evaluation Supporting Clinical Decision.
Vai A; Molinelli S; Rossi E; Iacovelli NA; Magro G; Cavallo A; Pignoli E; Rancati T; Mirandola A; Russo S; Ingargiola R; Vischioni B; Bonora M; Ronchi S; Ciocca M; Orlandi E
Cancers (Basel); 2022 Feb; 14(5):. PubMed ID: 35267415
[TBL] [Abstract][Full Text] [Related]
73. Intensity modulated proton therapy (IMPT) - The future of IMRT for head and neck cancer.
Moreno AC; Frank SJ; Garden AS; Rosenthal DI; Fuller CD; Gunn GB; Reddy JP; Morrison WH; Williamson TD; Holliday EB; Phan J; Blanchard P
Oral Oncol; 2019 Jan; 88():66-74. PubMed ID: 30616799
[TBL] [Abstract][Full Text] [Related]
74.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [New Search]
